EULAR definition of difficult-to-treat rheumatoid arthritis

Autor: Nagy, G., Roodenrijs, N.M., Welsing, P.M., Kedves, M., Hamar, A., van der Goes, M.C., Kent, A., Bakkers, M., Blaas, E., Senolt, L., Szekanecz, Z., Choy, E., Dougados, M., Jacobs, J.W., Geenen, R., Bijlsma, H.W., Zink, A., Aletaha, D., Schoneveld, L., van Riel, P., Gutermann, L., Prior, Y., Nikiphorou, E., Ferraccioli, G., Schett, G., Hyrich, K.L., Mueller-Ladner, U., Buch, M.H., McInnes, I.B., van der Heijde, D., van Laar, J.M., Leerstoel Geenen, Clinical Psychology (overkoepelend voor heel KP)

Publikováno v: Annals of the Rheumatic Diseases, 80(1), 31-35. BMJ PUBLISHING GROUP
Annals of the Rheumatic Diseases
Annals of the Rheumatic Diseases, 80(1), 31. BMJ Publishing Group
Annals of the Rheumatic Diseases, 80, 1, pp. 31-35
Annals of the Rheumatic Diseases, 80, 31-35

BackgroundDespite treatment according to the current management recommendations, a significant proportion of patients with rheumatoid arthritis (RA) remain symptomatic. These patients can be considered to have ‘difficult-to-treat RA’. However, un

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa22a2a60250fffbf8da475ee2e797f7
https://ard.bmj.com/content/annrheumdis/80/1/31.full.pdf